Growing old with cystic fibrosis

December 2005
Thorax;Dec2005 Supplement 2, Vol. 60, pii27
Academic Journal
The article presents abstracts of medical research related to cystic fibrosis. They include "Osteoclast Formation Potential From Haematopoietic Precursors is Altered During Infective Exacerbation in Adult Cystic Fibrosis Patients," by E. Shead, C. Haworth, E. Gunn, D. BiIton, M. Scott, G. Wakley and J. Compston, "Long Term Effects of Diabetes and Insulin treatment on Clinical Status and Lung Function in Cystic Fibrosis," by K. Mohan, K. Israel, H. Miller, P. Dyce, M.J. Ledson, and M.J. Waishaw, and "Right Ventricular Diastolic Function and C-reactive Protein Circulating Levels Correlate to Survival in Adults with Cystic Fibrosis," by R. Sabit, A. Ionescu, A.A. Ionescu, C.E. Bolton, L.S. Nixon, and D.J. Shale.


Related Articles

  • Preschool LCI Predicts Future Lung Function.  // Pulmonary Reviews;May2011, Vol. 16 Issue 5, p23 

    The article reviews the article "Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis," by . Aurora, S. Stanojevic, A. Wade et al which appeared in the March 15, 2011 issue of the "American Journal of Respiratory and Critical Care Medicine."

  • Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis. Flight, William G.; Bright-Thomas, Rowland J.; Tilston, Peter; Mutton, Kenneth J.; Guiver, Malcolm; Morris, Julie; Webb, A. Kevin; Jones, Andrew M. // Thorax;Mar2014, Vol. 69 Issue 3, p247 

    Background Viral respiratory infection (VRI) is a common cause of pulmonary exacerbations in children with cystic fibrosis (CF). The importance of VRI in adult CF populations is unclear. Objective To determine the incidence and clinical impact of VRI among adults with CF. Methods One hundred...

  • Lung inflammation: Disarming neutrophils in cystic fibrosis. Leavy, Olive // Nature Reviews Immunology;Jan2008, Vol. 8 Issue 1, p8 

    The article presents a medical research in Great Britain on reducing neutrophils in cystic fibrosis. It is said that the accumulation of neutrophils and high concentrations of the chemokine interleukin-8 (IL-8) in the airways is a characteristic feature of chronic lung diseases. However, further...

  • CYSTIC FIBROSIS ASSESSMENT AND TREATMENT.  // Thorax;Dec2001 Supp, Vol. 56, piii82 

    This article presents various studies related to cystic fibrosis (CF) assesment and treatment. Forced expiratory volume of less than 30% predicted has been reported as a prognostic indicator for outcome in patients with CF. The management of cystic fibrosis related diabetes is becoming...

  • Fasting hyperglycemia upon hospital admission is associated with higher pneumonia complication rates among the elderly. Castellanos, Mario R.; Szerszen, Anita; Saifan, Chadi; Zigelboym, Irina; Khoueiry, Georges; Rafeh, Nidal Abi; Wetz, Robert V.; Kleiner, Morton; Aoun, Nelly; Weiserbs, Kera F.; Maniatis, Theodore; Rothman, Jeffrey // International Archives of Medicine;2010, Vol. 3, p16 

    Background: Hyperglycemia is an independent predictor of adverse outcomes during hospitalization. In patients who have pneumonia, significant hyperglycemia is associated with poor outcomes. This study evaluates the interaction of the degree of hyperglycemia and complication rates stratified by...

  • A story of success: continuous quality improvement in cystic fibrosis care in the USA. Quon, Bradley S.; Goss, Christopher H. // Thorax;Dec2011, Vol. 66 Issue 12, p1106 

    Background Continuous quality improvement (CQI) in healthcare can be described as a reiterative approach to improving processes to reduce unexpected variation in health outcomes. CQI represents one model to achieve quality improvement (QI) and has long been recognized as a key to success in the...

  • tgAAVCF: will Phase II failure be the straw that breaks investors' backs?  // PharmaWatch: Monthly Review;May2005, Vol. 4 Issue 5, p21 

    The article reports on the failure of the phase II clinical trial of the Targeted Genetics' proprietary adeno-associated virus vector cystic fibrosis (tgAAVCF) therapy in the U.S. The phase II clinical trials reveals that it had failed to improve lung function in patients with mild to moderate...

  • Fixing cystic fibrosis CFTR with correctors and potentiators. Off to a good start. Elborn, J. Stuart // Thorax;Jan2012, Vol. 67 Issue 1, p4 

    The author reflects on the results of several studies on treating cystic fibrosis (CF) with correctors and potentiators. He states that numerous in vitro and animal studies suggests that it is possible to correct the cystic fibrosis transmembrane regulator (CFTR) and will make a significant...

  • The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD). Garrod, Rachel; Marshall, Johanna; Barley, Elizabeth; Fredericks, Salim; Hagan, Gerry // Primary Care Respiratory Journal;Aug2007, Vol. 16 Issue 4, p236 

    Aims: To examine relationships between markers of systemic inflammation and functional status in patients with chronic obstructive pulmonary disease (COPD). Methods: 41 COPD patients were stratified using the Medical Research Council (MRC) dyspnoea scale. Six-minute walking distance (6MWD),...


Read the Article


Sign out of this library

Other Topics